Company Overview of Metastatin Pharmaceuticals, Inc.
Metastatin Pharmaceuticals, Inc. develops cytostatic and antimetastatic therapies for the management of cancer in the United States. Its therapies focus on controlling tumor progression and metastasis using molecularly targeted compounds. The company’s compound includes ‘Uteroglobin’ that inhibits cell growth, invasiveness, and angiogenesis. Metastatin Pharmaceuticals, Inc. is headquartered in Bethesda, Maryland. As of March 1, 2007, Metastatin Pharmaceuticals, Inc. is a subsidiary of Samaritan Pharmaceuticals Inc.
6701 Democracy Boulevard
Bethesda, MD 20817
Key Executives for Metastatin Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Akros Pharma Inc.||United States|
|NutraCea/Cura, LLC||United States|
|Life Plus International||United States|
|Y's Therapeutics Inc.||United States|
|Velocity Pharmaceutical Development, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Metastatin Pharmaceuticals, Inc., please visit www.metastatin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.